The FDA says J&J's (JNJ -0.3%) bedaquiline for treating a drug-resistant form of...

|By:, SA News Editor

The FDA says J&J's (JNJ -0.3%) bedaquiline for treating a drug-resistant form of tuberculosis appears to be "safe and well-tolerated," although the highest dose could cause a small change in the heart's rhythm. J&J is seeking accelerated, temporary approval of bedaquiline; an FDA advisory committee is due to review the drug on Wednesday.